Literature DB >> 30910254

Clinical value screening, prognostic significance and key pathway identification of miR-204-5p in endometrial carcinoma: A study based on the Cancer Genome Atlas (TCGA), and bioinformatics analysis.

Shi Guo1, Jie Yang1, Man Wu1, Guohong Xiao2.   

Abstract

BACKGROUND: Endometrial carcinoma is one of the common carcinomas in the female reproductive system. It is reported that miR-204-5p is down-regulated in endometrial carcinoma. However, the mechanism and key pathways of miR-204-5p in endometrial carcinoma have not been clarified. MATERIAL/
METHODS: We evaluated the expression profiles and prognostic value of miR-204-5p expression in endometrial carcinoma by using bioinformatics analysis of a public dataset from TCGA. Drug of endometrial carcinoma from DrugBank, GO analysis, KEGG analysis, PPI network, mutation, as well as assessment of the prognostic significance were performed to the overlapping target genes of miR-204-5p in endometrial carcinoma. The relative expression levels of miR-204-5p target genes in endometrial carcinoma, including SF3B1, FBXW7, SPOP, and BRD4, were assessed by real-time quantitative polymerase chain reaction (RT-qPCR).
RESULTS: First, through DrugBank website, we obtained target drugs for endometrial carcinoma. MiR-204-5p expression was found to be lower in the endometrial carcinoma tissues than in adjacent normal tissues from TCGA. Next, we identified 143 genes as potential targets of miR-204-5p. Then, through GO enrichment analysis, KEGG signaling pathway and PPI analysis, we revealed the key networks in endometrial carcinoma. Next, mutation and assessment of the prognostic significance of endometrial carcinoma were obtained. At last, in endometrial carcinoma, the relative expression of SF3B1 and BRD4 increased, and the relative expression of FBXW7 decreased.
CONCLUSIONS: MiR-204-5p is down-regulated in endometrial carcinoma and affects the prognostic significance of endometrial carcinoma, which might play an important role in the tumorigenesis of endometrial carcinoma.
Copyright © 2019. Published by Elsevier GmbH.

Entities:  

Keywords:  Carcinoma; Computational biology; Endometrial; MiR-204-5p; RT-qPCR; TCGA

Mesh:

Substances:

Year:  2019        PMID: 30910254     DOI: 10.1016/j.prp.2019.02.007

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  9 in total

1.  Predicting Recurrence in Endometrial Cancer Based on a Combination of Classical Parameters and Immunohistochemical Markers.

Authors:  Peng Jiang; Jin Huang; Ying Deng; Jing Hu; Zhen Huang; Mingzhu Jia; Jiaojiao Long; Zhuoying Hu
Journal:  Cancer Manag Res       Date:  2020-08-18       Impact factor: 3.989

2.  Remote ischemic preconditioning protects against cerebral ischemia injury in rats by upregulating miR-204-5p and activating the PINK1/Parkin signaling pathway.

Authors:  Yiming Jiao; Jinlan Wang; Yanjie Jia; Mengzhou Xue
Journal:  Metab Brain Dis       Date:  2022-01-24       Impact factor: 3.584

3.  Biotransformation of the Mycotoxin Zearalenone to its Metabolites Hydrolyzed Zearalenone (HZEN) and Decarboxylated Hydrolyzed Zearalenone (DHZEN) Diminishes its Estrogenicity In Vitro and In Vivo.

Authors:  Sebastian Fruhauf; Barbara Novak; Veronika Nagl; Matthias Hackl; Doris Hartinger; Valentina Rainer; Silvia Labudová; Gerhard Adam; Markus Aleschko; Wulf-Dieter Moll; Michaela Thamhesl; Bertrand Grenier
Journal:  Toxins (Basel)       Date:  2019-08-20       Impact factor: 4.546

4.  Determining the Clinical Value and Critical Pathway of GTPBP4 in Lung Adenocarcinoma Using a Bioinformatics Strategy: A Study Based on Datasets from The Cancer Genome Atlas.

Authors:  Zhiqian Zhang; Juan Wang; Jiayan Mao; Fangqiong Li; Wei Chen; Wei Wang
Journal:  Biomed Res Int       Date:  2020-10-19       Impact factor: 3.411

5.  A Nomogram Model Involving Immunohistochemical Markers for Predicting the Recurrence of Stage I-II Endometrial Cancer.

Authors:  Peng Jiang; Mingzhu Jia; Jing Hu; Zhen Huang; Ying Deng; Zhuoying Hu
Journal:  Front Oncol       Date:  2021-01-22       Impact factor: 6.244

6.  MicroRNA-641 Inhibits Endometrial Cancer Progression via Targeting AP1G1.

Authors:  Yanfen Dong; He Yang; Handan Hua
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-30       Impact factor: 2.650

Review 7.  Fertility preservation in endometrial cancer patients: options, challenges and perspectives.

Authors:  Milan Terzic; Melanie Norton; Sanja Terzic; Gauri Bapayeva; Gulzhanat Aimagambetova
Journal:  Ecancermedicalscience       Date:  2020-05-06

Review 8.  Small Non-Coding-RNA in Gynecological Malignancies.

Authors:  Shailendra Kumar Dhar Dwivedi; Geeta Rao; Anindya Dey; Priyabrata Mukherjee; Jonathan D Wren; Resham Bhattacharya
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.575

Review 9.  MicroRNA as Epigenetic Modifiers in Endometrial Cancer: A Systematic Review.

Authors:  Amélia Favier; Grégoire Rocher; Annette K Larsen; Romain Delangle; Catherine Uzan; Michèle Sabbah; Mathieu Castela; Alex Duval; Céline Mehats; Geoffroy Canlorbe
Journal:  Cancers (Basel)       Date:  2021-03-06       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.